DK3173382T3 - Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker - Google Patents

Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker Download PDF

Info

Publication number
DK3173382T3
DK3173382T3 DK14898173.1T DK14898173T DK3173382T3 DK 3173382 T3 DK3173382 T3 DK 3173382T3 DK 14898173 T DK14898173 T DK 14898173T DK 3173382 T3 DK3173382 T3 DK 3173382T3
Authority
DK
Denmark
Prior art keywords
wolfram
reproduction
effectiveness
salts
improving
Prior art date
Application number
DK14898173.1T
Other languages
English (en)
Inventor
Bugié Agnès Arbat
Almazán Ignacio Canals
Original Assignee
Oxolife Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxolife Sl filed Critical Oxolife Sl
Application granted granted Critical
Publication of DK3173382T3 publication Critical patent/DK3173382T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00Compounds of tungsten
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00Compounds of tungsten
    • C01G41/02Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Powder Metallurgy (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Inorganic Insulating Materials (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
DK14898173.1T 2014-07-21 2014-07-21 Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker DK3173382T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2014/070586 WO2016012632A1 (es) 2014-07-21 2014-07-21 Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético, así como para mejorar la eficacia de las técnicas de reproducción asistida

Publications (1)

Publication Number Publication Date
DK3173382T3 true DK3173382T3 (da) 2023-03-13

Family

ID=55162540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14898173.1T DK3173382T3 (da) 2014-07-21 2014-07-21 Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker

Country Status (28)

Country Link
US (1) US10376540B2 (da)
EP (1) EP3173382B1 (da)
JP (1) JP6534439B2 (da)
KR (1) KR102282865B1 (da)
CN (1) CN106715332B (da)
AR (1) AR101252A1 (da)
AU (1) AU2014401750B2 (da)
BR (1) BR112017001287A2 (da)
CA (1) CA2955914C (da)
DK (1) DK3173382T3 (da)
ES (1) ES2940465T3 (da)
FI (1) FI3173382T3 (da)
HR (1) HRP20230223T1 (da)
HU (1) HUE061726T2 (da)
IL (1) IL250212B (da)
LT (1) LT3173382T (da)
MX (1) MX383705B (da)
PL (1) PL3173382T3 (da)
PT (1) PT3173382T (da)
RS (1) RS64025B1 (da)
RU (1) RU2679623C2 (da)
SG (1) SG11201700485VA (da)
SI (1) SI3173382T1 (da)
SM (1) SMT202300086T1 (da)
TW (1) TWI709407B (da)
UY (1) UY36222A (da)
WO (1) WO2016012632A1 (da)
ZA (1) ZA201701241B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4585253A3 (en) 2018-05-29 2025-10-08 NuLife B.V. Method for enhancing embryo implantation
EP4368577A1 (en) 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates
WO2026008874A1 (en) 2024-07-05 2026-01-08 Oxolife, S.L. Tungsten (vi) salts for use for increasing ongoing pregnancies, for increasing live birth rates and/or for increasing the biochemical pregnancy rate in infertile women

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (da) * 1973-07-27 1977-02-25 Anvar
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (es) 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2202314C2 (ru) * 2001-04-11 2003-04-20 Алексей Иванович Ступко Способ подготовки пациентки к искусственному оплодотворению
ES2187276B1 (es) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
AU2002368261A1 (en) * 2002-10-02 2004-04-23 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
DK1523985T3 (da) * 2003-10-17 2010-05-31 Neurofood Ab Oy Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
US7700280B2 (en) * 2003-12-31 2010-04-20 The Penn State Research Foundation Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer
JP2008544994A (ja) * 2005-07-05 2008-12-11 ファーティリティ テクノロジーズ ピーティーワイ リミテッド 妊娠結果を改善する方法および組成物
WO2007014970A1 (es) * 2005-07-29 2007-02-08 Universidad De Barcelona Composiciones farmacéuticas que comprenden una sal de tungsteno (vi) para el tratamiento de trastornos neurodegenerativos, en particular alzheimer y esquizofrenia
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
AU2007311444B2 (en) * 2006-10-18 2012-11-29 Periness Ltd. Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
ES2478790B1 (es) 2013-01-22 2015-05-06 Oxolife, S. L. Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)

Also Published As

Publication number Publication date
IL250212B (en) 2020-06-30
ZA201701241B (en) 2022-05-25
MX2017000927A (es) 2017-05-01
RS64025B1 (sr) 2023-03-31
MX383705B (es) 2025-03-14
EP3173382B1 (en) 2023-01-04
US20170173074A1 (en) 2017-06-22
SMT202300086T1 (it) 2023-05-12
EP3173382A1 (en) 2017-05-31
SG11201700485VA (en) 2017-02-27
ES2940465T3 (es) 2023-05-08
TWI709407B (zh) 2020-11-11
HUE061726T2 (hu) 2023-08-28
JP2017523170A (ja) 2017-08-17
KR20170029627A (ko) 2017-03-15
WO2016012632A9 (es) 2017-05-18
FI3173382T3 (fi) 2023-03-25
AU2014401750A1 (en) 2017-02-09
RU2679623C2 (ru) 2019-02-12
NZ728467A (en) 2021-04-30
AU2014401750B2 (en) 2019-10-24
CA2955914A1 (en) 2016-01-28
EP3173382A4 (en) 2018-03-21
KR102282865B1 (ko) 2021-07-28
PL3173382T3 (pl) 2023-05-08
HRP20230223T1 (hr) 2023-04-14
US10376540B2 (en) 2019-08-13
CA2955914C (en) 2022-09-06
IL250212A0 (en) 2017-03-30
RU2017105257A3 (da) 2018-08-21
SI3173382T1 (sl) 2023-04-28
CN106715332A (zh) 2017-05-24
CN106715332B (zh) 2019-01-29
RU2017105257A (ru) 2018-08-21
LT3173382T (lt) 2023-03-27
AR101252A1 (es) 2016-12-07
WO2016012632A1 (es) 2016-01-28
JP6534439B2 (ja) 2019-06-26
UY36222A (es) 2016-01-29
TW201618796A (zh) 2016-06-01
PT3173382T (pt) 2023-03-10
BR112017001287A2 (pt) 2018-01-30

Similar Documents

Publication Publication Date Title
DK3295951T3 (da) Anti-pvrig-antistoffer og fremgangsmåder for anvendelse
DK3148579T3 (da) Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3206493T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3386534T3 (da) Sammensætninger og fremgangsmåder til internalisering af enzymer
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3280441T3 (da) Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf
DK3183774T3 (da) Indretning og fremgangsmåde til ledning af elektromagnetiske bølger
DK3227262T3 (da) Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
DK3548033T3 (da) Forbindelser og deres fremgangsmåde til anvendelse
DK3129912T3 (da) Fremgangsmåde og system til sikring af data
IL251988A0 (en) Glycan-interacting compounds and methods of use
DK3350341T3 (da) Fremgangsmåder til diagnosticering og evaluering af non-alkoholisk steatohepatitis
DK3368663T3 (da) Virusfri cellelinjer og fremgangsmåder til opnåelse deraf
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3253412T3 (da) Anti-cd40l-antistoffer og fremgangsmåder til behandling af cd40l-forbundne sygdomme eller forstyrrelser
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3393688T3 (da) Fremgangsmåde og indretning til genindvinding af salt
DK3347015T3 (da) Fremgangsmåder til diagnosticering og behandling af adfærdsforstyrrelser
DK3200815T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3114540T3 (da) Neuralt netværk og fremgangsmåder til træning af neuralt netværk
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3341379T3 (da) EZH2-hæmmere